A Study of STSA-1002 in Healthy Subjects

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This study is a Phase Ib, randomized, double-blind, placebo-controlled, multiple dose, dose escalation safety, tolerability,pharmacokinetic and pharmacodynamic study of STSA-1002 injection in healthy subjects. A total of 26 healthy subjects were enrolled in three dosage groups.
Epistemonikos ID: 2898f6788b7191ff178197230ae8282e20c4e6fd
First added on: May 13, 2024